New report finds link between social media and poor mental health among young people

November 23, 2018
Medical Communications

Young people between the ages of 11 and 19, living with a mental disorder, were more likely to use social …

nhs_andrew_tatlow

NHS hospitals paying 167% more for drugs since 2010/11

November 23, 2018
Medical Communications Cost, NHS, UK, hospitals, pricing

Medicines are costing the NHS more than 50% more than a decade ago, while hospitals are paying more than twice …

Pfizer’s Daurismo becomes first of its kind to secure FDA approval in acute myeloid leukaemia

November 22, 2018
Research and Development, Sales and Marketing AML, Daurismo, FDA, Pfizer, US, leukaemia

Pfizer has revealed that the FDA has chosen to approve its Daurismo (glasdegib) for the treatment of newly-diagnosed acute myeloid …

Cancer Drugs Fund to offer MSD’s Keytruda for lung cancer

November 22, 2018
Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NICE, UK, keytruda, pharma

MSDโ€™s Keytruda (pembrolizumab) will now be made available via the Cancer Drugs Fund for patients in England, as NICE announces …

gsk_china_2_2_0_1

GSK retain top spot on access to medicines list

November 22, 2018
Business Services, Research and Development GSK, J&J, JJ, R&D, Sanofi, access, low and middle income countries, researh

The majority (63%) of research and development projects are being conducted by just five companies; GSK, Johnson & Johnson, Sanofi, …

Probiotics have no effect on children with gastroenteritis, study shows

November 22, 2018
Research and Development children, flu, gastroenteritis, probiotics, research

Despite the claims of marketing campaigns and advertisements, probiotics have no effect on gastroenteritis on children, according to a new …

Uninsured patients elibible for no-cost replacement of medicines lost in California wildfires

November 22, 2018
Manufacturing and Production, Sales and Marketing USA, california, insurance, prescription, wildfires

Uninsured citizens in Californiaโ€™s Butte, Los Angeles and Ventura counties will be eligible for a no-cost replacement of medicines lost …

FDA approves first ever therapy for ultra rare primary haemophagocytic lymphohistiocytosis

November 21, 2018
Research and Development, Sales and Marketing FDA, Novimmune, pharma, sobi

The partnership of Sobi and Novimmune has revealed that their interferon gamma (IFNฮณ) blocking antibody Gamifant (emapalumab-lzsg) has received approval …

Mylan’s Morgantown plant receives FDA warning letter

November 21, 2018
Research and Development Mylan, pharma

Generic drugmaker Mylan has received a warning letter from the FDA over concerns surrounding the firmโ€™s manufacturing plant in West …

ian_hudson

MHRA Chief to step down in 2019

November 21, 2018
Medical Communications, Research and Development MHRA, UK, brexit, pharma

The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …

Pfizer ask Senator Cindy Hyde-Smith to refund campaign donation after ‘public hanging’ comments

November 21, 2018
Research and Development Pfizer, cindy hyde smith, donations, politics, public hanging

American pharma giant Pfizer have asked Mississippi Republican Senator Cindy Hyde-Smith to return campaign donations after the candidate was filmed …

Brexit referendum led to rise in antidepressant prescriptions

November 21, 2018
Research and Development

The result of the Brexit referendum led to an increase in prescriptions for antidepressants, according to a study conducted by …

First-ever all-oral drug for sleeping sickness recommended for approval by EMA committee

November 20, 2018
Manufacturing and Production, Sales and Marketing CHMP, EMA, Europe, Sanofi, fexinidazole, pharma, sleeping sickness

Sanofiโ€™s fexinidazole, the first all-oral therapy for the treatment of human African trypanosomiasis (HAT), or sleeping sickness, has secured a …

shutterstock_138095450

Opioid dependency therapy price hiked 600% since 2014, Senate investigators find

November 20, 2018
Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma

Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …

shutterstock_159488225

Merck KGaA and Pfizer’s Bavencio falls short in ovarian cancer

November 20, 2018
Manufacturing and Production, Research and Development Bavencio, Cancer, Merck MGaA, Pfizer, ovarian cancer, pharma

Merck KGaA and Pfizerโ€™s Bavencio (avelumab) has missed its primary endpoints in the treatment of platinum-resistant or -refractory ovarian cancer, …

Pfizer to resume price hiking in 2019; 41 drugs set to increase

November 20, 2018
Manufacturing and Production, Sales and Marketing Pfizer, Trump, pharma, price hikes, price hiking, pricing

American pharma firm Pfizer has revealed plans to increase the prices of 41 medicines, the equivalent of 10% of its …

lilly_entrance_web

Eli Lilly’s Emgality cleared for treatment of migraine in Europe

November 20, 2018
Manufacturing and Production, Sales and Marketing EU, Eli Lilly, Emgality, Europe, migraine, pharma

Eli Lillyโ€™s Emgality (galcanezumab) has secured approval from the European Commission for the prophylaxis of migraine in adult patients who …

Novartis’ Promacta cleared by FDA for first-line use in severe aplastic anaemia

November 19, 2018
Sales and Marketing FDA, Novartis, Promacta, Revolade, US, aplastic anaemia, pharma

Novartis has secured expanded approval from the FDA for Promacta (eltrombopag), allowing it to now be used in combination with …

arnaud_breabout

Mundipharma name GSK veteran as new Senior Vice President & CFO

November 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, Mundipharma, arnaud breabout, cfo, svp, wsenior vice president

The Mundipharma network today confirmed the appointment of Arnaud Breabout, to the position of Senior Vice President & Chief Financial …

roche_dark_0

Roche withdraws Tecentriq combo application in first-line renal cell carcinoma

November 19, 2018
Sales and Marketing Cancer, Roche, avastin, pharma, renal cell carcinoma, tecentriq

The EMA has revealed that Roche has chosen to withdraw its marketing application for immunotherapy Tecentriq (atezolizumab) in combination with …

The Gateway to Local Adoption Series

Latest content